-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) has a strong underlying genetic factor
Although the risk of AD is high, people have realized that there is considerable phenotypic diversity among APOE ε4 homotypes, from early-onset AD to life-long no symptoms of cognitive impairment
There is considerable phenotypic diversity among APOE ε4 homotypes, ranging from early-onset AD to lifelong symptoms without cognitive impairment .
Using data from a large-scale AD-related genome-wide association study ( GWAS ), researchers developed a polygenic risk score (PRS) and used it to predict the risk of AD
GWAS diagnosis
Researchers evaluated the polygenic risk score (PRS) between cognitively healthy APOE ε4 isotypes (n = 213) aged ≥75 years and early-onset APOE ε4 isotype AD cases (n = 223) aged ≤65 years.
The density map shows the difference in the distribution of polygenic risk scores between the case and the control group at the extremes of lipoprotein E (APOE)ε4/ε4 and APOEε3/ε3 extremes
The density map shows the difference in the distribution of polygenic risk scores between the case and the control group at the extreme lipoprotein E (APOE) ε4/ε4 and APOEε3/ε3 extreme.APOE ε4 same type AD cases have significantly higher PRS APOE ε4 same type AD cases have significantly higher PRS APOE ε3/ε3 similar PRS differences between extreme phenotypes are not so obvious APOE ε3/ε3 similar PRS differences between extreme phenotypes No difference Then there is no statistical difference in education level PRS, there is no statistical difference in education level PRS
In short, the PRS of AD helps to change our perception of the extreme risk phenotype of APOE ε4/ε4 genotype
Original source:
Original source:Aamira J.
Aamira J.
Leave a message here